Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 16Active not recruiting 12Terminated 8Unknown 7Recruiting 5Withdrawn 3

Sponsor Class

OTHER 6NIH 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Genitourinary 7

Conditions

Nasopharyngeal Carcinoma 20Prostatic Neoplasms 7Breast Neoplasms 7Head and Neck Neoplasms 6Esophageal Squamous Cell Carcinoma 6Esophageal Neoplasms 6Rectal Neoplasms 4Radiation Injuries 4Carcinoma, Squamous Cell 4Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 3Nasopharyngeal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Recurrence 2Lung Neoplasms 2Vulvar Neoplasms 1Thyroid Neoplasms 1Sinonasal undifferentiated carcinoma 1Radiation 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Obesity 1Neurotoxicity Syndromes 1Neoplasms 1

Interventions

Docetaxel 21Radiosurgery 19Radiotherapy 17Androgen Antagonists 14Leuprolide 11Goserelin 11bicalutamide 9enzalutamide 8Surveys and Questionnaires 8Prednisone 8Brachytherapy 8Blood Specimen Collection 8Abiraterone Acetate 8acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7Radiotherapy, Intensity-Modulated 7Multiparametric Magnetic Resonance Imaging 7Gonadotropin-Releasing Hormone 7Triptorelin Pamoate 6pembrolizumab 4cabazitaxel 4abiraterone 4Standard of Care 4Positron Emission Tomography Computed Tomography 4Metformin 4Heavy Ion Radiotherapy 4Exercise 4Estramustine 4luprolide acetate gel depot 3darolutamide 3Watchful Waiting 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT01802242 2024-03-18

Tumor TARGET Prostate Cancer

University Health Network, Toronto

Phase NA Unknown
85 enrolled
Genitourinary

Prostatic Neoplasms

NCT01968538 2023-02-28

Metabolomic Study for Localized Prostate Cancer

Georgetown University

Unknown
400 enrolled
Genitourinary

Prostatic Neoplasms

NCT01618851 2023-02-22

Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer

Georgetown University

Phase NA Unknown
70 enrolled
Genitourinary

Prostatic Neoplasms

NCT01764646 2020-05-19

Hypofractionated Radiation Therapy in Prostate Cancer

University Hospital, Geneva

Phase NA Unknown
170 enrolled
Genitourinary

Prostatic Neoplasms

NCT00126802 2016-07-06

The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer

AHS Cancer Control Alberta

Phase 1/2 Unknown
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT00452556 2014-03-19

The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study

Nova Scotia Cancer Centre

Phase 2 Unknown
86 enrolled
Genitourinary

Prostatic Neoplasms

NCT00946543 2013-08-26

Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
198 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡